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Glaucoma is characterized by a progressive optic nerve degeneration and retinal ganglion cell loss, but the underlying biological
basis for the accompanying neurodegeneration is not known. Accumulating evidence indicates that structural and functional
abnormalities of astrocytes within the optic nerve head (ONH) have a role in glaucomatous neurodegeneration. Here, we
investigate the impact of activation of cyclic adenosine 3′,5′-monophosphate (cAMP)/protein kinase A (PKA) pathway on
mitochondrial dynamics of ONH astrocytes exposed to oxidative stress. ONH astrocytes showed a significant loss of astrocytic
processes in the glial lamina of glaucomatous DBA/2J mice, accompanied by basement membrane thickening and collagen
deposition in blood vessels and axonal degeneration. Serial block-face scanning electron microscopy data analysis demonstrated
that numbers of total and branched mitochondria were significantly increased in ONH astrocytes, while mitochondrial length
and volume density were significantly decreased. We found that hydrogen peroxide- (H2O2-) induced oxidative stress
compromised not only mitochondrial bioenergetics by reducing the basal and maximal respiration but also balance of
mitochondrial dynamics by decreasing dynamin-related protein 1 (Drp1) protein expression in rat ONH astrocytes. In contrast,
elevated cAMP by dibutyryl-cAMP (dbcAMP) or isobutylmethylxanthine treatment significantly increased Drp1 protein
expression in ONH astrocytes. Elevated cAMP exacerbated the impairment of mitochondrial dynamics and reduction of cell
viability to oxidative stress in ONH astrocytes by decreasing optic atrophy type 1 (OPA1), and mitofusin (Mfn)1/2 protein
expression. Following combined treatment with H2O2 and dbcAMP, PKA inhibition restored mitochondrial dynamics by
increasing mitochondrial length and decreasing mitochondrial number, and this promoted cell viability in ONH astrocytes.
Also, PKA inhibition significantly promoted Akt/Bax phosphorylation and Mfn1/2 oligomerization in ONH astrocytes. These
results suggest that modulation of the cAMP/PKA signaling pathway may have therapeutic potential by activating Akt/Bax
phosphorylation and promoting Mfn1/2 oligomerization in glaucomatous ONH astrocytes.
1. Introduction
Glaucoma is a complex, multifactorial optic neuropathy
characterized by a slow and progressive degeneration of the
optic nerve, including retinal ganglion cell (RGC) axons,
leading to visual impairment [1, 2]. The factors contributing
to axon degeneration and astrocyte dysfunction in the optic
nerve head (ONH) in primary open-angle glaucoma (POAG)
are not well understood. Increasing evidence indicates that
compromised astrocyte structure and function accompanied
by RGC axon loss have been reported in the ONH of exper-
imental glaucoma models and patients with POAG [3–8].
Astrocytes are the responsible cell type for many
pathological alterations in the oxidative stress-mediated
glaucomatous ONH degeneration [3, 6, 7, 9–13]. Since
oxidative stress has long been thought to be an important
pathophysiological mechanism in many neurodegenerative
diseases including glaucoma [3, 10, 14–16], the activation of
the cyclic adenosine 3′,5′-monophosphate (cAMP)/protein
kinase A (PKA) signaling pathway exacerbates vulnerability
to oxidative stress in ONH astrocytes [7]. The ubiquitous sec-
ond messenger cAMP in the central nervous system contrib-
utes to numerous biological processes including cell growth
and death [17–20]. Upon stimulation, cAMP synthesis and
its degradation are tightly regulated by adenylyl cyclases
and cyclic nucleotide phosphodiesterases (PDEs), respec-
tively [18]. Accumulating evidence indicates that the
increased level of cAMP is associated with the unstimulated
glaucomatous ONH astrocytes from patients with POAG
[21] as well as experimental glaucoma [7, 20]. Nevertheless,
the precise cellular and molecular mechanism(s) of the acti-
vation of the cAMP/PKA signaling pathway underlying
astrocyte dysfunction in glaucomatous ONH degeneration
remains to be determined. In this regard, mitochondria have
been suggested to have a key role.
In healthy cells, mitochondria are autonomous and mor-
phologically dynamic organelles that structurally reflect a
precise balance of ongoing dynamics, fission, and fusion,
within a cell [22–24]. This balance is regulated by a family
of dynamin-related GTPases that exert opposing effects.
The mitofusins (Mfns) and optic atrophy type 1 (OPA1)
are required for mitochondrial fusion, whereas dynamin-
related protein 1 (Drp1) regulates mitochondrial fission
[23–25]. Accumulating evidence indicates that compromised
mitochondrial dynamics or function is associated with
human ONH astrocytes from patients with POAG and rat
ONH astrocytes exposed to oxidative stress in vitro, as well
as glaucomatous ONH astrocytes in DBA/2J mice, an exten-
sively characterized strain that spontaneously develops
elevated intraocular pressure (IOP) [6, 9, 26–28]. Despite
the widely appreciated glaucoma relevance of impaired
mitochondrial dynamics and subsequent mitochondrial
dysfunction [28–34], our understanding of the signaling
mechanisms that impair mitochondrial structure and func-
tion in glaucomatous ONH astrocytes is still in its infancy.
Accordingly, these mechanisms may be relevant to oxidative
stress and/or cAMP/PKA pathway-mediated mitochondrial
dysfunction [3, 10, 14–16].
In the present study, we investigate the impact of the
activation of the cAMP/PKA pathway on mitochondrial
dynamics in ONH astrocytes exposed to oxidative stress.
2. Materials and Methods
2.1. Animals. Pregnant Sprague-Dawley rats (250-300 g in
weight; Envigo, Placentia, CA, USA) and adult female
DBA/2J and DBA/2J-Gpnmb+ (D2-Gpnmb+) mice (The
Jackson Laboratory, Bar Harbor, ME, USA) were housed in
covered cages, fed with a standard rodent diet ad libitum,
and kept on a12 h light/12 h dark cycle. All procedures con-
cerning animals were in accordance with the Association
for Research in Vision and Ophthalmology Statement for
the Use of Animals in Ophthalmic Vision Research and
under protocols approved by Institutional Animal Care and
Use Committee at the University of California, San Diego.
2.2. Reagents and Other Materials. Chemicals and other
materials were obtained from the following sources:
hydrogen peroxide (H2O2), dibutyryl-cAMP (dbcAMP),
and H89 from Sigma, St. Louis, MO, USA; 8CPT-6phenyl-
cAMP from Biolog; DMEM/F12 (1 : 1), MEM+GlutaMax™,
100x penicillin/streptomycin (Pen/Strep), and fetal bovine
serum from Thermo Fisher Scientific, Waltham, MA, USA;
Superscript™ II reverse transcriptase from Invitrogen; RNase
inhibitor, dNTP mixture, and oligo (dT) from Promega;
polymerase chain reaction (PCR) master mix, protein size
marker, and SuperSignal® West Pico and Femto chemilumi-
nescent substrates from Thermo Fisher Scientific; and
Amersham Hybond™-P polyvinylidenedifluoride (PVDF)
membrane and ECL™ Prime Western Blotting Detection
Reagent from GE Healthcare (Chicago, IL, USA).
2.3. Tissue Preparation. Mice were anesthetized with intra-
peritoneal injection of a mixture of ketamine (100mg/kg,
Ketaset; Fort Dodge Animal Health, Fort Dodge, IA, USA)
and xylazine (9mg/kg, TranquiVed; Vedco, Inc., St. Joseph,
MO, USA) before cervical dislocation. For electron micros-
copy (EM), the ONHs were dissected from the choroids
and fixed in 2% paraformaldehyde and 2.5% glutaraldehyde
(Ted Pella, Redding, CA, USA) in 0.15M sodium cacodylate
(pH7.4, Sigma) at 37°C for 1 h.
2.4. Primary ONH Astrocyte Culture. Primary rat ONH
astrocytes were prepared with minor modifications as previ-
ously described [7, 9]. Briefly, after euthanizing with CO2 gas,
10–20 pieces of ONH tissue were dissected from postnatal
day 5 Sprague-Dawley rats and transferred to a 35mm petri
dish with 2ml 0.2% bovine serum albumin/Dulbecco’s PBS
(DPBS). Under a dissecting microscope, remnant tissues
were removed, and the ONH tissue was identified and dis-
sected using microscissors and a sharp blade. The ONH tis-
sues were minced and transferred to a 60mm petri dish
and conditioned with growth medium: MEM+GlutaMax™
supplemented with 10% FBS and 100x Pen/Strep and incu-
bated at 5% CO2 at 37
°C. After incubation for 1-2 weeks,
the ONH explants were removed by 70 μm cell strainers
(BD Biosciences, San Diego, CA, USA). The cells that were
grown from the ONH explants were plated in a 100mm cul-
ture dish and cultured until 80% confluence. For further
purification of the ONH astrocytes, the culture dish was
shaken for 16 h at room temperature, followed by growth
medium changing with serum free medium, and the cells
were incubated for 24 h at 5% CO2 at 37
°C. After removing
nonadherent cells, the adherent ONH astrocytes were col-
lected, centrifuged, and plated on poly-L-lysine-coated
culture dishes.
2.5. Transmission Electron Microscopy (TEM). For TEM
analysis, ONH tissues were fixed via cardiac perfusion with
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solution at 37°C in 2% paraformaldehyde and 2.5% glutaral-
dehyde (Ted Pella) in 0.15M sodium cacodylate (pH7.4) and
placed in precooled fixative on ice for 1 h as previously
described [9, 29, 32]. The ONH tissues were embedded in
Durcupan ACM resin (Fluka, St. Louis, MO, USA). Ultrathin
(70 nm) sections were poststained with uranyl acetate and
lead salts and evaluated with a JEOL 1200FX transmission
EM operated at 80 kV (Tokyo, Japan). Images were recorded
on film at 8000x magnification. For quantitative analysis, the
number of astrocytic mitochondria was normalized to the
total area occupied by astrocytes in each image, which was
measured using ImageJ (National Institute of Health,
Bethesda, MD, USA). Mitochondrial lengths were measured
with ImageJ. The mitochondrial volume density, defined
as the volume occupied by mitochondria divided by the
volume occupied by the cytoplasm, was estimated using
stereology as follows. A 112 × 112 square grid (112 × 112
chosen for ease of use with Photoshop) was overlaid on
each image loaded in Photoshop (Adobe System, San Jose,
CA, USA), and the mitochondria and cytoplasm lying
under intercepts were counted. The relative volume
occupied by mitochondria was expressed as the ratio of
intercepts coinciding with this organelle relative to the
intercepts coinciding with cytoplasm.
2.6. Serial Block-Face Scanning Electron Microscopy (SBEM).
For SBEM analysis, ONH tissues were washed with cacody-
late buffer for 2 h at 4°C and then placed into cacodylate
buffer containing 2mM CaCl2 and 2% OsO4/1.5% potassium
ferrocyanide as previously described [6, 32]. The tissues were
left for 2 h at room temperature. After thorough washing in
double distilled water, the tissues were placed into 0.05%
thiocarbohydrazide for 30min. The slices were again washed
and then stained with 2% aqueous OsO4 for 1 h. The tissues
were washed and then placed into 2% aqueous uranyl acetate
overnight at 4°C. The tissues were washed with water at room
temp and then stained with en bloc lead aspartate for 30min
at 60°C. The tissues were washed with water and then dehy-
drated on ice in 50%, 70%, 90%, 100%, and 100% ethanol
solutions for 10min at each step. The tissues were then
washed twice in dry acetone and then placed into 50 : 50 Dur-
cupan ACM : acetone overnight. The tissues were transferred
to 100% Durcupan resin overnight. The tissues were then
embedded and left in an oven at 60°C for 72 h. SBEM data
was collected with a 3View unit (Gatan Inc., Pleasanton,
CA, USA) installed on a Merlin field emission SEM (Carl
Zeiss Microscopy, Thornwood, NY, USA). The ONH vol-
umes were collected in 2.0 to 2.4 kV accelerating voltages,
with a raster size of 24k × 24k and pixel dwell time of
0.5-1 μs. The pixel sizes were 4.0-7.3 nm, depending on
the raster size, and section thickness was 60-70 nm. Once
a volume was collected, the histograms for the tissues
throughout the volume stack were normalized to correct
for drift in image intensity during acquisition. Digital
micrograph files (.dm4) were normalized using Digital
Micrograph and then converted to MRC format. The
stacks were converted to eight bit, and volumes were
manually traced for reconstruction and analysis using
IMOD software (http://bio3d.colorado.edu/imod/) [35].
2.7. Cell Viability. Cell viability was measured using 3-[4, 5-
dimethylthiazol-2yl]-2, 5-diphenyl tetrazolium bromide
(MTT) according to the manufacturer’s recommendations
(Cell Proliferation Kit I; Roche Diagnostics, Basel, Switzer-
land) as previously described [7, 9, 32]. Briefly, ONH astro-
cytes were plated on a 96-well plate (0:5~1 × 104 per well).
After 48 h, the cells were treated with various reagents for
1 h and 10 μl MTT stock solution was added to each well
including the negative control. The cells were incubated for
4 h in a humidified atmosphere of a 5% CO2 incubator at
37°C, and 100μl of solubilization solution was added to
dissolve the formazan crystals that remained in the wells.
After overnight incubation at 5% CO2 at 37
°C, the absor-
bance at 560 and 690nm was measured with a microplate
reader (SpectraMax; Molecular Devices, San Jose, CA,
USA). Each set of data was collected from multiple replicate
wells of each experimental group (n = 3).
2.8. Mitochondrial Morphology. Mitochondria in the ONH
astrocytes were labeled by the addition of a red fluorescent
mitochondrial dye (100 nM final concentration; MitoTracker
Red CMXRos; Invitrogen, Carlsbad, CA, USA) to the cul-
tures as previously described [6, 9] and were maintained for
20min in a CO2 incubator. The cultures were subsequently
fixed with 4% paraformaldehyde (Sigma) in DPBS for
30min at 4°C. For three-dimensional (3D) reconstruction,
images were obtained with an optical section separation
(z-interval) of 0.25 μm by an Olympus FluoView1000
(Olympus Corp., Tokyo, Japan). Isosurface rendition was
obtained from the stack using Imaris 6.4.2 (Bitplane AG,
Zurich, Switzerland).
2.9. Western Blot. Cells were harvested and lysed for 30min
on ice with a modified RIPA lysis buffer (150mM NaCl,
1mM EDTA, 1% NP-40, 0.1% SDS, 1mM DTT, 0.5%
sodium deoxycholate, and 50mM Tris-Cl, pH7.6), contain-
ing complete protease inhibitors. The lysates were centri-
fuged at 15000 g for 15min, and the protein amounts in the
supernatants were measured by Bradford methods. Proteins
(5-10 μg) were separated by SDS/PAGE and electrotrans-
ferred to the PVDF membrane. The membrane was blocked
with 5% nonfat dry milk and PBS/0.1% Tween-20 (PBS-T)
for 1 h, incubated with primary antibodies overnight at 4°C.
Primary antibodies are rabbit polyclonal anti-Akt antibody
(1 : 5000; Cell Signaling, Danvers, MA, USA), mouse mono-
clonal anti-phospho-Akt (Ser437) antibody (S473, 1 : 2000;
Cell Signaling), mouse monoclonal anti-Bax antibody (N-
20; 1 : 2000; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), rabbit polyclonal anti-phospho-Bax (Ser184) antibody
(1 : 2000; Cell Signaling), mouse monoclonal anti-Drp1 anti-
body (1 : 5000; BD Biosciences), mouse monoclonal anti-
OPA1 antibody (1 : 5000; BD Biosciences), mouse monoclo-
nal anti-Mfn1 and anti-Mfn2 antibody (1 : 3000; Abcam,
Cambridge, UK), and mouse monoclonal anti-actin antibody
(1 : 100,000; Millipore, Burlington, MA, USA). After several
washes in PBS-T, the membranes were incubated with
peroxidase-conjugated goat anti-mouse or rabbit IgG
(1 : 5000; Bio-Rad, Hercules, CA, USA) and developed using
an enhanced chemiluminescence substrate system. The
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images were captured and quantified by using an Image-
Quant™ LAS 4000 system (GE Healthcare Bio-Science),
and the band densities were normalized to the band densities
for actin.
2.10. Reverse Transcription- (RT-) PCR and Quantitative
Real-Time RT-PCR. Total RNA was isolated from the cells
using the RNeasy mini kit (Qiagen, Hilden, Germany),
according to the manufacturer’s protocol, as previously
described [7]. cDNAs were synthesized from total RNAs with
SuperScript II reverse transcriptase and oligo (dT) primers
according to the manufacturer’s protocols. RT-PCR was
performed with cDNAs synthesized from 0.1 μg of the total
RNA of each cell as a template and specific primers
(Table 1). RT-PCR products were electrophoresed on a 2%
agarose gel and visualized by ethidium bromide staining.
For the quantification of the relative mRNA expressions of
each group, real-time PCR was carried out using a
MX3000P real-time PCR system (Stratagene, San Diego,
CA, USA) as follows. cDNAs were amplified using iQ™ SYBR
Green super-mix (Bio-Rad) and the specific primers for 40
cycles (initial incubation at 50°C for 2min and then at 95°C
for 10min, and 40 cycles (95°C for 15 sec, 55°C for 1min,
and 72°C for 1min)). Output data were obtained as Ct values
and the differential mRNA expression of each gene among
samples was calculated using the comparative Ct method.
GAPDH mRNA, an internal control, was amplified along
with the target genes, and the Ct value of GAPDH was used
to normalize the expression of target genes.
2.11. Mitochondrial Respiration. Cells (2 × 104 per well) were
seeded into Seahorse XF24-well plates approximately 24 h
before the measurement. Oxygen consumption rate (OCR)
was measured using an XF24 analyzer (Agilent, Santa Clara,
CA, USA) as previously described [36]. After measuring the
basal respiration, oligomycin (2 μg/ml, Sigma), an inhibitor
of adenosine triphosphate (ATP) synthesis; carbonyl cyanide
4-(trifluoromethoxy) phenylhydrazone (FCCP; 0.3μM,
Sigma), the uncoupler; and rotenone (2μM, Sigma), an
inhibitor of mitochondrial complex I, were sequentially
added to measure maximal respiration.
2.12. Statistical Analyses. Data were presented as the
mean ± S:D. Comparison of experimental conditions was
evaluated using the two-tailed unpaired Student’s t-test
between groups or one-way analysis of variance followed
by Tukey’s post hoc test among groups. P < 0:05 was con-
sidered to be statistically significant.
3. Results
3.1. Mitochondrial Fission and Loss in Glaucomatous ONH
Astrocytes. Structural and functional abnormalities have been
implicated in ONH astrocytes with glaucoma progression
[6, 9, 26, 28, 37]. The SBEM data set showed degenerative
structural changes in the astrocytes of the glial lamina in
glaucomatous DBA/2J mice (Figure 1). Compared with
nonglaucomatous control D2-Gpnmb+ mice (Figure 1(a)),
glaucomatous ONH astrocytes showed a significant loss
of astrocytic processes in the glial lamina, accompanied
by basement membrane thickening and collagen deposi-
tion in the blood vessel, as well as axonal degeneration
(Figure 1(b)). Using 3D reconstruction segmentations
from the SBEM stack, our results revealed separated and
branched mitochondria, as well as nucleus in astrocyte
somas in both groups (Figures 1(c)–1(e)). Quantitative
analysis of mitochondrial morphology showed that numbers
of total mitochondria and branched mitochondria were
significantly increased in glaucomatous ONH astrocytes
compared with D2-Gpnmb+ mice (Figure 1(f)). However,
mitochondrial lengths and volume density were significantly
decreased in glaucomatous ONH astrocytes compared with
D2-Gpnmb+ mice (Figure 1(f)). In good agreement with
these results, compared with nonglaucomatous D2-Gpnmb+
mice, TEM or SBEM data set analyses from glaucomatous
DBA/2J mice consistently showed degenerative axons and
myelins in the ON (Figure 2(a)) and mitochondrial fragmen-
tation in the ONH axons (Figure 2(b)) [32].
3.2. Oxidative Stress Impairs Mitochondrial Bioenergetics and
Alters Mitochondrial Dynamics by Decreasing Drp1 Protein
Expression in ONH Astrocytes.Oxidative stress triggers mito-
chondrial dysfunction in ONH astrocytes by altering the oxi-
dative phosphorylation (OXPHOS) complex (Cx), reducing
cellular ATP production, and increasing reactive oxygen spe-
cies (ROS) generation [9]. Using the Seahorse XF24 Flux
Analyzer, we assessed mitochondrial respiration by directly
measuring the OCR in ONH astrocytes following oxidative
stress induced by H2O2 (50μM) as previously reported
[7, 9]. Bioenergetic profile analysis showed that oxidative
stress significantly decreased the basal and maximal respi-
rations by 72 ± 10 and 99 ± 5 pmols/min compared with
control cells by 96 ± 6 and 175 ± 13 pmols/min, respec-
tively (Figure 3(a)). Of interest, our results demonstrated
that oxidative stress significantly decreased total Drp1 pro-
tein expression, whereas there were no significant changes
of the expression levels of OPA1 as well as Mfn1 and
Mfn2 proteins in ONH astrocytes (Figure 3(b)). In addi-
tion, quantitative real-time RT-PCR analysis demonstrated
that there were no statistically significant differences in the
expression levels of Drp1 and OPA1 as well as Mfn1 and
Mfn2 genes in ONH astrocytes exposed to H2O2 com-
pared with control cells (Figure 3(c)).
3.3. Elevated Intracellular cAMP Alters Mitochondrial
Dynamics by Increasing Drp1 Protein Expression in ONH
Astrocytes. Our previous study demonstrated that forskolin-
induced intracellular cAMP elevation impaired ONH
Table 1: Primer sequences.
Forward primer Reverse primer
Drp1 cgaaaactgtctgcccgaga gctgccctactaattcactc
Mfn1 gtgaagttcacaagtgcaaa gctcgggtggagaaactgct
Mfn2 gctgacctggaccaccagag tggctttgctctgaagtgaa
OPA1 gagtcgaagtcgatccaagc cgcctaacttcggtgtttgt
GAPDH agaacatcatccctgcatcc gtcctcagtgtagcccagga
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astrocytes and prolonged elevation of cAMP-induced
caspase-3-mediated cell death in ONH astrocytes [7]. To
determine whether elevated cAMP alters mitochondrial
dynamics and cell viability/mitochondrial activity in ONH
astrocytes, we treated cells with dbcAMP, which is a cell-
permeable analog of cAMP that mimics the action of
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Figure 1: Mitochondrial fission and loss in the ONH astrocytes of the glial lamina in glaucomatous DBA/2J mice. (a) A representative SBEM
micrograph showing normal healthy morphology of astrocytes, axons, and a blood vessel in the glial lamina of aged matched
nonglaucomatous control D2-Gpnmb+ mice. (b) A representative SBEM micrograph showing a significant loss of astrocytic processes and
axonal degeneration as well as basement membrane thickening and collagen deposition in the blood vessels in the glial lamina of
glaucomatous DBA/2J mice. (c–e) Representative 3D reconstruction micrographs showed separated (red) and branched (green)
mitochondria, as well as the nucleus (blue) in ONH astrocyte somas in both groups. Scale bars, 10 μm. (f) Quantitative analysis of
mitochondrial number, lengths, and volume density as well as branched mitochondrial number in ONH astrocyte somas. Data are shown
as the mean ± SEM (SBEM, n = 2 mice/group; n = 4 ONH astrocytes/group). ∗ and ∗∗∗ denote P < 0:05 and P < 0:001, respectively.
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endogenous cAMP in cultured ONH astrocytes. We
observed that dbcAMP treatment significantly increased
total Drp1 protein expression in ONH astrocytes, whereas
the expression levels of OPA1 as well as Mfn1 and Mfn2
protein were not significantly changed in ONH astrocytes
(Figure 4(a)). We further observed that dbcAMP
treatment increased cell viability/mitochondrial activity
dose-dependently in ONH astrocytes by MTT assay
(Figure 4(b)). To confirm whether exogenous cAMP treat-
ment itself reduces cell viability/mitochondrial activity or
not, we further treated with 8CPT-6phenyl-cAMP, a natural
cAMP analog with enhanced cell permeability and potent
activator of PKA, and compared it to dbcAMP treatment in
ONH astrocytes. We found that cell viability/mitochondrial
activity was significantly decreased in ONH astrocytes by
8CPT-6phenyl-cAMP treatment in a dose-dependent man-
ner, while dbcAMP treatment slightly increased cell viability
(Figure 4(c)).
3.4. Elevated Intracellular cAMP Exacerbates Abnormality of
Mitochondrial Dynamics in ONH Astrocytes Exposed to
Oxidative Stress. Because elevated intracellular cAMP exacer-
bated vulnerability to oxidative stress in ONH astrocytes
in vitro and was also associated with compromised ONH
astrocytes in glaucomatous DBA/2J mice in vivo [7], we
further investigated whether elevated cAMP exacerbates
abnormality of mitochondrial dynamics to oxidative stress
in ONH astrocytes. We observed that lower concentration
(25 μM) of dbcAMP together with H2O2 (50μM) did not
change the cell viability/mitochondrial activity in ONH
astrocytes compared with H2O2 treatment alone. However,
higher concentration (125 μM) of dbcAMP with H2O2
(50 μM) significantly decreased the cell viability/mitochon-
drial activity compared with H2O2 treatment alone
(Figure 5(a)). Although dbcAMP is a membrane permeable
cAMP analog, the intracellular concentration of dbcAMP
reaches only 3 to 5% of dbcAMP applied extracellularly in
D2-Gpnmb+ DBA/2J
(a)
DBA/2J: fragmented axonal mitochondria
A B C
(b)
Figure 2: Mitochondrial fission in axonal degeneration of the glial lamina in glaucomatous DBA/2J mice. (a) Representative TEM
micrographs showed normal healthy morphology of axons and myelins, as well as astrocytic processes in the glial lamina of aged matched
nonglaucomatous control D2-Gpnmb+ mice. However, representative TEM micrographs showed a significant loss of axon and myelins as
well as disrupted astrocytic processes in the glial lamina of glaucomatous DBA/2J mice. Scale bars, 20 nm. (b) Representative 3D
reconstruction micrographs from a SBEM data set showed highly fragmented mitochondria (several colors) in the axons of the glial
lamina in glaucomatous DBA/2J mice. The arrow indicates damaged axon bundle. Scale bars, 10 μm (C) and 1 μm (A and B).
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the cell culture media, and importantly, only a small amount
(~ 0.7μM) of N6-monobuturyl-cAMP, a biologically active
derivative of dbcAMP, could be detected when dbcAMP
was applied in extracellular concentrations of 1mM
[38, 39]. In addition, the order of antiproliferative activity cor-
related with the membrane permeability determined in the
HPLC experiments (8‐CPT‐cAMP > dbcAMP > 8‐Br‐cAMP)
[38]. These data could explain why the lower amount of
dbcAMP (25μM) does not reduce cell viability after oxidative
stress in contrast to the higher amount of dbcAMP (100μM).
We have used the concentration (100μM) of dbcAMP to per-
form a combined treatment with H2O2 in the present study
(Figures 5(b) and 5(c)). Intriguingly, we observed that elevated
cAMP induced by dbcAMP restored total Drp1 protein
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Figure 3: Effects of oxidative stress on mitochondrial bioenergetics and dynamics in ONH astrocytes. (a) OCR changes in ONH astrocytes
treated with H2O2 (50 μM) for 1 h. Oligomycin A and FCCP were sequentially added at the indicated time point. Basal respiration indicates
the starting basal OCR and the value which was set to 100%. Maximum respiration represents the ratio between FCCP uncoupled OCR and
basal OCR. (b) Western blot analyses for the protein expression of Drp1, OPA1, and Mfn1 and Mfn2 in ONH astrocytes treated with H2O2
(50 μM) for 1 h. Note that oxidative stress induced loss of Drp1 protein expression in ONH astrocytes. (c) Real-time RT-PCR analysis for the
mRNA expression ofDrp1, OPA1, andMfn1 andMfn2 genes in ONH astrocytes treated with H2O2 (50 μM) for 1 h. Note that oxidative stress
did not change gene expression. For each determination, the expression levels of mRNAs and proteins in controls were normalized to a value
of 100% and 1.0, respectively. Data are shown as the mean ± S:D: (n = 3). ∗∗ and ∗∗∗ denote P < 0:01 and P < 0:001, respectively.
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expression in ONH astrocytes exposed to H2O2 up to the nor-
mal level like nontreated control cells compared with control
cells exposed to H2O2 alone (Figures 5(b) and 5(c)), whereas
elevated cAMP significantly decreased OPA1 as well as Mfn1
and Mfn2 protein expression in ONH astrocytes exposed to
H2O2 (Figures 5(b) and 5(c)).
3.5. PKA Inhibition Restores Mitochondrial Dynamics in
ONH Astrocytes against Oxidative Stress and cAMP
Elevation. We next determined the effect of PKA inhibition
on mitochondrial dynamics in ONH astrocytes against oxi-
dative stress combined with cAMP elevation. Using H89, a
PKA inhibitor, we inhibited the PKA pathway in ONH astro-
cytes exposed to H2O2 and dbcAMP for 1 h. We further
determined mitochondrial morphology in ONH astrocytes
using MitoTracker Red staining, a marker for mitochondria
[6, 9] and quantified mitochondrial length and number. As
shown in Figure 5, our results demonstrated that control
ONH astrocytes contained classic elongated tubular mito-
chondria. However, we observed the induction of mitochon-
drial fission in ONH astrocytes exposed to H2O2 compared
with control cells (Figure 6(a)). We observed that intracellu-
lar cAMP elevation promoted an increase in mitochondrial
fission and contained small rounded mitochondria in ONH
astrocytes exposed to H2O2 compared with ONH astrocytes
exposed to H2O2 alone (Figure 6(a)). Notably, this extensive
mitochondrial fission by oxidative stress combined with
cAMP elevation restored the mitochondrial morphology of
ONH astrocytes by PKA inhibition like ONH astrocytes
exposed to H2O2 alone (Figure 6(a)). Consistent with our
data of worsening ONH astrocyte viability, quantitative anal-
yses showed that oxidative stress combined with cAMP ele-
vation induced a more severe decrease of mitochondrial
length, but an increase of mitochondrial number in ONH
astrocytes exposed to H2O2 compared with control cells
exposed to H2O2 alone (Figure 6(b)). Of note, PKA inhibi-
tion significantly restored the mitochondrial length and
number in ONH astrocytes against oxidative stress combined
with cAMP elevation up to the level like ONH astrocytes
exposed to H2O2 alone (Figure 6(b)).
3.6. PKA Inhibition Promotes Oligomerization of Mfn1 and
Mfn2 and Phosphorylation of Akt and Bax in ONH
Astrocytes against Oxidative Stress and cAMP Elevation. We
determined the effect of PKA inhibition on oligomerization
of Mfn1 andMfn2 in ONH astrocytes against oxidative stress
combined with cAMP elevation. Our results demonstrated
that PKA inhibition significantly increased expression levels
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Figure 4: Effects of elevated intracellular cAMP on mitochondrial bioenergetics and dynamics in ONH astrocytes. (a) Western blot analyses
for the protein expression of Drp1, OPA1, and Mfn1 and Mfn2 in ONH astrocytes treated with dbcAMP (100 μM) for 1 h. Note that elevated
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of oligomerization of Mfn1 and Mfn2 in ONH astrocytes
against oxidative stress combined with cAMP elevation
(Figure 7(a)). Since PKA inhibition protects ONH astrocytes
by increasing Akt phosphorylation at Ser437 against oxida-
tive stress [7] and Akt regulates Bax phosphorylation at
Ser184, inhibiting Bax effects on the mitochondria [40], we
further determined the effect of PKA inhibition on Akt and
Bax phosphorylation in ONH astrocytes against oxidative
stress combined with cAMP elevation. We observed that
PKA inhibition promoted cell viability/mitochondrial
activity in ONH astrocytes against oxidative stress combined
with cAMP elevation (Figure 7(b)). Our results demonstrated
that PKA inhibition significantly promoted the phosphoryla-
tion of Akt at Ser437 and Bax at Ser184 in ONH astrocytes
against oxidative stress combined with cAMP elevation
(Figure 7(b)). Collectively, our findings suggest that inhibi-
tion of the cAMP/PKA pathway promotes the survival of
ONH astrocytes against oxidative stress combined with
cAMP elevation by Akt/Bax phosphorylation-mediated
Mfn1 and Mfn2 oligomerization (Figure 8).
4. Discussion and Conclusion
We demonstrated that glaucomatous ONH astrocytes
showed unbalanced mitochondrial dynamics by increasing
excessive mitochondrial fission and loss, and this was
accompanied by the compromised blood vessels and
degenerative axons. We also observed that elevated intra-
cellular cAMP exacerbated abnormality of mitochondrial
dynamics of ONH astrocytes exposed to oxidative stress
by impairing mitochondrial fusion activity. Notably, inhi-
bition of the PKA pathway promoted the survival of
ONH astrocytes against oxidative stress combined with
elevated cAMP by increasing Akt/Bax phosphorylation
and Mfn1/2 oligomerization.
The role of astrocytes is considered to be critical in neu-
roprotection or neurodestruction during glaucomatous
ONH degeneration [3, 5–7, 10, 37, 41, 42]. While compro-
mised ONH astrocytes have been reported in human patients
with glaucoma and experimental animal models of glaucoma
[3, 5–7, 10, 37], the pathophysiological mechanisms
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Figure 5: Effects of elevated intracellular cAMP on mitochondrial dynamics in ONH astrocytes exposed to oxidative stress. ONH astrocytes
exposed to H2O2 (50 μM) were cotreated with dbcAMP (25 or 125μM) for 1 h. (a) Cell viability/mitochondrial activity analysis using MTT
assay in ONH astrocytes. Note that elevated intracellular cAMP accelerated loss of cell viability in ONH astrocytes exposed to H2O2 compared
with ONH astrocytes exposed to H2O2 alone. (b, c) Western blot analyses for the protein expression of Drp1, OPA1, and Mfn1 and Mfn2.
Note that elevated intracellular cAMP induced loss of total OPA1 and Mfn1 and Mfn2 protein expression in ONH astrocytes exposed to
H2O2 compared with ONH astrocytes exposed to H2O2 alone. For each determination, the cell viability and protein expression in controls
were normalized to a value of 1.0. Data are shown as the mean ± S:D: (n = 3). ∗, ∗∗, and ∗∗∗ denote P < 0:05, P < 0:01, and P < 0:001,
respectively.
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underlying astrocyte dysfunction in glaucomatous ONH
degeneration are not fully understood. A previous study has
proposed that impairment of the blood supply in the ONH
by glaucomatous insult leads to the degeneration of fortified
astrocytes (FASTs) that subsequently induces the restriction
of FAST processes, and that this leads to axon loss by energy
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Figure 6: Effects of PKA inhibition on mitochondrial morphology in ONH astrocytes against combined oxidative stress and cAMP elevation.
ONH astrocytes exposed to H2O2 (50 μM) were cotreated with dbcAMP (100 μM) and/or H89 (10 μM) for 1 h. (a) MitoTracker Red staining
of mitochondria in ONH astrocytes treated with H2O2 and/or dbcAMP. Scale bars, 10μm. (b) Quantitative analysis of mitochondrial number
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deprivation [5]. We have demonstrated for the first time that
severe glaucoma damage triggered not only a significant loss
of astrocytic processes but also degeneration of astrocytes in
the glial lamina of glaucomatous DBA/2J mice [6, 7]. In the
present study, our results further demonstrated the corre-
sponding evidence of a significant loss of astrocytic processes
in glaucomatous glial lamina of DBA/2J mice, accompanied
by basement membrane thickening and collagen deposition
in the blood vessels and axonal degeneration. Hence, we
propose that elevated IOP initiates astrocyte alterations that
lead to delayed ONH astrocyte dysfunction by sustained
glaucomatous stress and that this dysfunctional activity of
ONH astrocytes exacerbates susceptibility of axon loss by
diminishing their functional support to RGC axons.
Oxidative stress links to not only mitochondrial dysfunc-
tion but also glial dysfunction during glaucoma progression
[6, 10, 27, 31–33, 43–46]. Accumulating evidence indicates
that vascular abnormalities induced by elevated IOP and/or
hypoxia result in oxidative stress, and that leads to
mitochondrial dysfunction and subsequent energy failure
during glaucomatous ONH degeneration. In the ONH,
human astrocytes and lamina cribrosa cells in vitro from
patients with glaucoma showed evidence of oxidative
stress, bioenergetic dysfunction, or mitochondrial dysfunc-
tion by compromising mitochondrial dynamics [6, 27]. Since
glutamate excitotoxicity is a well-known source of oxidative
stress, our previous study has also demonstrated that glauco-
matous human ONH astrocytes from patients with glaucoma
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upregulated expression levels of N-methyl-D-aspartate
receptors and GLAST protein, as well as promoted
mitochondrial fission [6]; this suggests that oxidative stress
is critical in the pathogenesis of glaucomatous optic neurop-
athy. Further, we have demonstrated that inhibition of oxida-
tive stress increased mitochondrial mass and improved
bioenergetic function in ONH astrocytes, while oxidative
stress impaired ONH astrocytes by compromising the regu-
lation of OXPHOS Cxs, as well as ATP production and
ROS generation [9]. Nevertheless, the precise mechanism of
the specific impairment in mitochondrial dynamics by which
oxidative stress results in ONH astrocyte dysfunction
remains elusive. In the present study, we revealed that a
transient induction of oxidative stress- (relatively lower con-
centration of H2O2) mediated mitochondrial bioenergetic
dysfunction is associated with the deficit of Drp1 protein
expression, accompanied by compromised cell viability
related to mitochondrial activity, but it did not show any rel-
evance with the change of mitochondrial fusion proteins
(OPA1 as well as Mfn1 and Mfn2) in ONH astrocytes. While
the increase of Drp1 expression impairs neuronal cells in
neurodegenerative diseases including Huntington’s disease,
Parkinson’s disease, and glaucoma [32, 47, 48], loss of Drp1
compromises bioenergetic function in axonal mitochondria,
and this leads to significant defects in maintaining the nor-
mal ATP level and synaptic vesicle cycling [49]. These collec-
tive results strongly suggest that oxidative stress-induced
Drp1 defects may impair mitochondrial dynamics and subse-
quently trigger mitochondrial bioenergetic dysfunction in
ONH astrocytes.
While the cAMP/PKA pathway has critical roles in a
variety of cellular functions including cell survival and
death [18, 19, 50, 51], there is surprisingly little known
to date about the cAMP/PKA pathway-mediated patho-
physiological signaling mechanism in injured ONH astro-
cytes during glaucomatous neurodegeneration. Emerging
evidence from our group unveiled a novel degenerative
signaling mechanism that activation of the intracellular
cAMP/PKA signaling pathway leads to the impairment
of ONH astrocytes by inhibiting Akt phosphorylation
and activating Bim/Bax activation and that this leads to
caspase-3 activation-mediated cell death [7]. Notably, this
finding was strongly supported by increasing expression
of cAMP and active Bax and caspase-3 proteins in the
ONH astrocytes of glaucomatous DBA/2J mice [7]. There-
fore, these findings suggest that activation of intracellular
cAMP signaling cascade is an important pathophysiologi-
cal mechanism in ONH astrocyte dysfunction and its sig-
nificance should be considered in the future studies of
glaucomatous ONH degeneration.
While accumulating evidence links cAMP signaling to
mitochondrial dynamics in mammalian cells, this connection
in ONH astrocytes remains unexplored. In contrast to oxida-
tive stress-induced Drp1 loss in ONH astrocytes, we here
demonstrated that the elevated intracellular cAMP level
increased mitochondrial fission Drp1 protein expression,
but not mitochondrial fusion proteins such as OPA1as well
as Mfn1 and Mfn2. These results raise the possibility that
Drp1 critically contributes to the alteration of mitochondrial
dynamics of ONH astrocyte dysfunction in response to oxi-
dative stress and/or intracellular cAMP elevation. Based on
our recent finding that elevated cAMP exacerbates vulnera-
bility to oxidative stress in ONH astrocytes [7], we further
addressed the effect of elevated cAMP on mitochondrial
dynamics in ONH astrocytes exposed to oxidative stress.
Our results demonstrated that elevated cAMP induced a sig-
nificant reduction of total OPA1 as well as Mfn 1 and Mfn2
protein expression in ONH astrocytes exposed to oxidative
stress, while total Drp1 protein expression was kept at a con-
trol level. Indeed, this surprising alteration of mitochondrial
dynamics was accompanied by a worse reduction of cell
viability related to mitochondrial activity in ONH astro-
cytes. Thus, these results suggest that elevated intracellular
cAMP level accelerates mitochondrial dysfunction of ONH
astrocytes exposed to oxidative stress through the impaired
activity of mitochondrial fusion, leading to ONH astrocyte
dysfunction and degeneration.
We have previously proposed that impairment of mito-
chondrial dynamics is linked to ONH astrocyte dysfunction
in glaucomatous neurodegeneration [6, 9]. Indeed, the
PKA 
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Figure 8: A hypothetical model for the notion that inhibition of the cAMP/PKA pathway promotes the survival of ONH astrocytes against
oxidative stress combined with cAMP elevation by Akt/Bax phosphorylation-mediated Mfn1 and Mfn2 oligomerization.
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increased excessive fission-mediated mitochondrial dysfunc-
tion was present in glaucomatous human and mouse ONH
astrocytes, as well as in oxidative stress-induced rat ONH
astrocytes in vitro [6, 9]. Nevertheless, there is no evidence
for impaired mitochondrial fusion activity in glaucomatous
ONH astrocytes. Mfn1 and Mfn2 are GTPase dynamin-like
proteins of the outer mitochondrial membrane, which are
essential for fusion activity in the mitochondria of human
cells [52–54]. While mutations of Mfn2 compromise motor
and sensory neurons in Charcot-Marie-Tooth disease [55],
overexpression of Mfn2 protects neuronal cells in the brain
against hypoxia-induced apoptosis or ischemia/reperfusion
[56, 57]. In addition, activated Mfn2 protects the mitochon-
dria by inhibiting Bax activation, cytochrome c release, and
permeability transition [58]. Recent evidence has reported
the decrease of Mfn1 and Mfn2 protein expression in the
ON of aged glaucomatous DBA/2J mice [59], raising the pos-
sibility that altered expression levels of Mfn1 and Mfn2 pro-
teins may contribute to glaucomatous ONH degeneration. In
the present study, we demonstrated for the first time that
elevated cAMP induced loss of Mfn1 and Mfn2 in ONH
astrocytes exposed to oxidative stress. More importantly,
PKA inhibition restored mitochondrial morphology and
promoted ONH astrocyte survival by increasing the oligo-
merization of both Mfn1 and Mfn2 against oxidative stress
combined with cAMP elevation. Thus, our findings suggest
that increasing the activity of Mfn1 and Mfn2 oligomeriza-
tion may have therapeutic potential to protect ONH astro-
cytes against glaucomatous insults.
Reduction of cAMP protects rat cortical astrocytes by
activating Akt pathway in vitro [60–62]. Indeed, emerging
evidence from our group revealed that the activation of the
cAMP/PKA signaling pathway was critical to the vulnerabil-
ity of oxidative stress-induced ONH astrocytes and that
inhibition of this activation of the cAMP/PKA pathway pro-
moted the survival of ONH astrocytes via increasing Akt
phosphorylation at Ser437 against oxidative stress [7]. Nota-
bly, we here demonstrated that PKA inhibition by H89
induced a significant increase of not only Akt phosphoryla-
tion at Ser437 but also Bax phosphorylation at Ser184 in
ONH astrocytes against oxidative stress combined with
cAMP elevation. Akt inhibits a conformational change in
the Bax protein and its translocation to mitochondria, lead-
ing to prevent mitochondrial dysfunction and cell death
[63]. Further, Akt regulates Bax phosphorylation at Ser184
which, in turn, inhibits Bax effects on the mitochondria
[40]. Since we have proposed a link of the pathological path-
way between cAMP/PKA activation and Akt/Bim/Bax-medi-
ated intrinsic cell death in ONH astrocyte dysfunction [7],
our results strongly suggest the notion that Akt/Bax phos-
phorylation by inhibiting the cAMP/PKA pathway would
be an important defense mechanism in glaucomatous ONH
astrocyte dysfunction.
Although H89 is a well-known PKA inhibitor, we pro-
pose that the use of H89 should be carefully interpreted due
to its nonspecific inhibitory effect on other kinases including
ribosomal S6 kinase 1 (S6K1). Indeed, H89 also inhibits S6K1
(80nM) at lower IC50 than PKA (135nM) in a kinase assay
in vitro [64]. Hence, H89 could be used in conjunction with
other PKA inhibitors, such as Rp-cAMPS or PKA analogs,
to investigate the effect of PKA [65, 66]. We have previ-
ously reported that PKA inhibition by H89 restored the
level of Akt phosphorylation by forskolin, an adenylyl
cyclase activator. Moreover, PKA inhibition by PKI, a
potent competitive synthetic peptide PKA inhibitor,
increases Akt phosphorylation in both normal and oxida-
tive stress conditions [7], demonstrating that PKA mediates
Akt phosphorylation in ONH astrocytes. However, we can-
not exclude the possibility that a direct inhibition of S6K1
by H89 may affect the level of Akt phosphorylation in
ONH astrocytes because S6K1 inhibition by PF-4708671,
a selective S6K1 inhibitor, also increases the level of Akt
phosphorylation in insulin treated-hepatocytes, but not in
the normal condition [67]. Therefore, it would be useful
to determine whether H89 regulates Akt phosphorylation
via solely PKA or in combination with other kinases such
as S6K1 in future studies.
We have previously raised a possibility that a transient
induction of oxidative stress with a relatively lower con-
centration of H2O2 (50 μM) triggers an endogenous mech-
anism by reducing the intracellular level of cAMP in ONH
astrocytes. In similar way, the result of the lower level of
Bax protein expression by H2O2 (50μM) treatment
(Figure 5(b)) also raises a possibility that an endogenous
compensatory mechanism induced by a lower concentra-
tion of H2O2 may trigger the reduction of Bax protein
expression in ONH astrocytes. While Bax does not alter
the activity of Mfn1-Mfn2 trans heterotypic complexes,
soluble Bax positively regulates mitochondrial fusion activ-
ity by Mfn2 homotypic complexes on mitochondria. It has
been suggested that cytoplasmic Bax is endogenously
phosphorylated most likely at Ser184, regulating heterodi-
merization of Bax with antiapoptotic Bcl-2 family mem-
bers [40]. Since Bax is phosphorylated only in the
cytoplasm, the soluble [40], nonoligomerized form of Bax is
the primary cytosolic regulator of mitochondrial fusion [68].
Thus, our findings also suggest that the cAMP/PKA-mediated
Akt/Bax pathway may control mitochondrial dynamics via
regulating oligomerization activity of Mfn1 and Mfn2 in
ONH astrocytes against oxidative stress.
In conclusion, we provide evidence that the activation of
the cAMP/PKA pathway has a critical role in the impairment
of mitochondrial dynamics and bioenergetics of ONH astro-
cytes. Moreover, elevated cAMP exacerbates mitochondrial
dysfunction to oxidative stress of ONH astrocytes. Inhibition
of the intracellular cAMP/PKA pathway can protect ONH
astrocytes by increasing Akt/Bax phosphorylation and
Mfn1 and Mfn2 oligomerization. Therefore, we suggest that
modulation of the cAMP/PKA pathway may have therapeu-
tic potential to protect ONH astrocytes by preserving the
mitochondrial network and function in glaucomatous ONH
degeneration.
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